How to appeal your OptumRx medication and prescription denial

Why OptumRx denies medication and prescription

OptumRx is UnitedHealth Group's pharmacy benefit manager and administers drug coverage for UHC commercial and Medicare Part D plans, plus many third-party employer groups. The appeal track mirrors UHC procedurally but is filed and decided separately from the medical benefit.

For medication and prescription specifically: Drug denials happen at the pharmacy benefit (PBM) layer, separate from the medical benefit. They include non-formulary drugs, GLP-1s, specialty injectables, brand-name vs. generic, and prior-auth-required medications.

What OptumRx denies for medication and prescription

The medication and prescription services most often denied:

• GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound)
• Specialty biologics (Humira, Stelara, Dupixent)
• ADHD medications (Vyvanse, Adderall XR)
• Hepatitis C antivirals
• Hormone replacement therapy
• Compounded medications
• Off-label prescription uses

Why medication and prescription claims get denied

A typical OptumRx medication and prescription denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:

• Drug not on plan formulary (non-formulary)
• Step therapy: cheaper alternative not tried first
• Quantity limit exceeded
• Plan claims indication not FDA-approved
• Diagnosis ICD doesn't match approved indication

The OptumRx appeal process

Appeal levels: Coverage determination / exception request, then plan-level redetermination, then external review (IRO commercial; IRE / MAXIMUS for Part D).

Carrier timing: Standard exception: 72 hours. Expedited: 24 hours. Redetermination filing window: 60 days for Part D, 180 days for commercial.

Medication timing: Urgent: 24-72 hours. Standard: 72 hours for Medicare Part D, 15 days for commercial. Filing window: typically 60 days.

What we know about OptumRx: Where the medical and pharmacy benefits both touch the same therapy (e.g. provider-administered biologics), we file parallel appeals in both lanes to avoid a procedural gap.

Common OptumRx denial patterns for medication and prescription

• Separate appeal track from UHC medical. An OptumRx denial is not a UHC medical denial, and vice versa. Filing the wrong appeal track is one of the most common preventable errors. We confirm whether the denial originated at the pharmacy benefit or the medical benefit before filing.
• Specialty drug routing through BriovaRx / Optum Specialty. Specialty injectables and infused biologics often route through Optum's specialty pharmacy. Denials at this layer require formulary-exception documentation with clinical rationale, prior-trial data, and (where applicable) FDA-label citation.
• Part D coverage determinations. OptumRx-administered Part D plans follow the federal 5-level Part D appeal ladder. The IRE for Part D escalation is MAXIMUS Federal Services. Tiering and formulary exceptions are filed before a coverage-determination challenge.

How to win your OptumRx medication and prescription appeal

Strategy for medication and prescription: Two paths: (1) tiering exception, request that the drug be moved to a covered tier; (2) formulary exception, request coverage of a non-formulary drug citing medical necessity. Manufacturer-published clinical packets accelerate exception filings.

Filed against OptumRx, that strategy rides on this procedural spine:

1. Procedural-rights anchor. Every OptumRx denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter invokes these in the opening paragraph to lock the timeline and force criteria disclosure.
2. Criteria-disclosure demand. OptumRx frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
3. Controlling-standard citation. Formulary tiering and exception rights, including the standard and expedited exception process ACA plans must offer under 45 C.F.R. § 156.122.
4. Treating-provider attestation. A letter from the treating physician addressing each criterion in OptumRx's own policy language. This is the single strongest evidentiary element.
5. Requested action. A specific demand to reverse the medication and prescription denial and approve the service, not a general "please reconsider."

Documents you'll need for your OptumRx medication and prescription appeal

• Denial letter from pharmacy benefit
• Prescription / Rx record
• Prescriber's notes on indication
• Documentation of prior step-therapy trials

What a medication and prescription appeal can recover

Typical recovery for medication and prescription cases runs $200 - $20,000+ per month of medication. The exact figure depends on the specific service and your plan's contracted rates.

OptumRx medication and prescription appeals: frequently asked questions

What Apellica does for OptumRx medication and prescription appeals

We file appeals against OptumRx specifically configured to its internal review process. Every medication and prescription appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.

Cost: $0 upfront. We work on contingency for OptumRx appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Related OptumRx guides

• OptumRx surgery denials appeal guide
• OptumRx mri and imaging denials appeal guide
• OptumRx medicare denials appeal guide
• OptumRx prior authorization denials appeal guide

Medication and prescription guides for other carriers

• UnitedHealthcare medication and prescription appeal guide
• Aetna (CVS Health) medication and prescription appeal guide
• Cigna (Evernorth) medication and prescription appeal guide
• Anthem / BlueCross BlueShield medication and prescription appeal guide